Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver FitzGerald

Showing results (121-130 of 288) with videos related to

Pageof 29
Sort By:
Arthritis Research & Therapy|December 20, 2024
Efficacy and safety of tofacitinib in an open-label, long-term extension study in patients with psoriatic arthritis who received adalimumab or tofacitinib in a Phase 3 randomized controlled study: a post hoc analysisDafna D Gladman, Peter Nash, Philip J Mease, et al.
Annals of the Rheumatic Diseases|December 1, 2010
Development of a preliminary composite disease activity index in psoriatic arthritisAizad Mumtaz, Phil Gallagher, Brian Kirby, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2002
Activation of nuclear orphan receptor NURR1 transcription by NF-kappa B and cyclic adenosine 5'-monophosphate response element-binding protein in rheumatoid arthritis synovial tissueAlice N McEvoy, Eithne A Murphy, Tiia Ponnio, et al.
Journal of Thoracic Imaging|November 26, 2010
Pulmonary fibrosis in systemic sclerosis: association with myocardial fibrosisPatrick J Nicholson, Christopher Hegarty, Melanie Jackson, et al.
BMC Musculoskeletal Disorders|June 3, 2018
Advanced practice physiotherapy-led triage in Irish orthopaedic and rheumatology services: national data auditOrna Fennelly, Catherine Blake, Oliver FitzGerald, et al.
BMC Rheumatology|August 31, 2022
Effect of tofacitinib on dactylitis and patient-reported outcomes in patients with active psoriatic arthritis: post-hoc analysis of phase III studiesAna-Maria Orbai, Philip J Mease, Philip S Helliwell, et al.
The Journal of Rheumatology|February 16, 2021
Evaluation and Validation of a Patient-completed Psoriatic Arthritis Flare QuestionnairePhilip S Helliwell, William Tillett, Robin Waxman, et al.
Arthritis Research & Therapy|November 30, 2013
Th17 and Th22 cells in psoriatic arthritis and psoriasisHelen Benham, Paul Norris, Jane Goodall, et al.
Arthritis and Rheumatism|May 30, 2006
Temporal expression pattern of Duffy antigen in rheumatoid arthritis: up-regulation in early diseaseLucy Gardner, Catherine Wilson, Angela M Patterson, et al.
Arthritis and Rheumatism|September 1, 2007
Early changes in serum type II collagen biomarkers predict radiographic progression at one year in inflammatory arthritis patients after biologic therapyRonan H Mullan, Clare Matthews, Barry Bresnihan, et al.
Pageof 29

Showing results (121-130 of 288) with videos related to

Sort By:
Pageof 29
Arthritis Research & Therapy|December 20, 2024
Efficacy and safety of tofacitinib in an open-label, long-term extension study in patients with psoriatic arthritis who received adalimumab or tofacitinib in a Phase 3 randomized controlled study: a post hoc analysisDafna D Gladman, Peter Nash, Philip J Mease, et al.
Annals of the Rheumatic Diseases|December 1, 2010
Development of a preliminary composite disease activity index in psoriatic arthritisAizad Mumtaz, Phil Gallagher, Brian Kirby, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2002
Activation of nuclear orphan receptor NURR1 transcription by NF-kappa B and cyclic adenosine 5'-monophosphate response element-binding protein in rheumatoid arthritis synovial tissueAlice N McEvoy, Eithne A Murphy, Tiia Ponnio, et al.
Journal of Thoracic Imaging|November 26, 2010
Pulmonary fibrosis in systemic sclerosis: association with myocardial fibrosisPatrick J Nicholson, Christopher Hegarty, Melanie Jackson, et al.
BMC Musculoskeletal Disorders|June 3, 2018
Advanced practice physiotherapy-led triage in Irish orthopaedic and rheumatology services: national data auditOrna Fennelly, Catherine Blake, Oliver FitzGerald, et al.
BMC Rheumatology|August 31, 2022
Effect of tofacitinib on dactylitis and patient-reported outcomes in patients with active psoriatic arthritis: post-hoc analysis of phase III studiesAna-Maria Orbai, Philip J Mease, Philip S Helliwell, et al.
The Journal of Rheumatology|February 16, 2021
Evaluation and Validation of a Patient-completed Psoriatic Arthritis Flare QuestionnairePhilip S Helliwell, William Tillett, Robin Waxman, et al.
Arthritis Research & Therapy|November 30, 2013
Th17 and Th22 cells in psoriatic arthritis and psoriasisHelen Benham, Paul Norris, Jane Goodall, et al.
Arthritis and Rheumatism|May 30, 2006
Temporal expression pattern of Duffy antigen in rheumatoid arthritis: up-regulation in early diseaseLucy Gardner, Catherine Wilson, Angela M Patterson, et al.
Arthritis and Rheumatism|September 1, 2007
Early changes in serum type II collagen biomarkers predict radiographic progression at one year in inflammatory arthritis patients after biologic therapyRonan H Mullan, Clare Matthews, Barry Bresnihan, et al.
Pageof 29